Russian invasion of Ukraine could affect more than 200 clinical trials across biotech and pharma

Russia's invasion of Ukraine is likely to impact millions of people, not just in the Eastern European nation but around the world as drug developers might face delays in clinical trials conducted in Kyiv and elsewhere.